Gwen Binder
Company: Cabaletta Bio
Job title: President, Science & Technology
Seminars:
Pursuing Clinical Trials in Autoimmunity to Expand Treatment Application & Increase Accessibility 1:30 pm
The dawn of autoimmune applications for cell therapies provides a new and expanded wider patient pool but requires unique considerations and challenges to overcome, compared to oncology. Repurposing current cell therapy products to specifically target autoimmune antigens Identifying a suitable disease indication to target with optimal clinical outcome Understanding unique regulatory requirements for autoimmune disease…Read more
day: Workshop E